• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for diagnosis

diagnosis

Bodywork: Understanding fatty liver disease

September 22, 2020

3D Illustration of Human Digestive System Liver Anatomy

What is fatty liver? What are its symptoms, causes and treatment?

Filed Under: Bodywork Tagged With: adam, bodywork, cohen, column, diagnosis, diet, disease, drug, Edmond, fatty liver, healthy, lijjun xia, medication, newsok, OKC, oklahoman, organ, physician, Prescott, stephen, steve, transplant

50 years after terminal diagnosis, Greg Kindell is still here

November 8, 2018

In 1968, doctors told Greg Kindell that he had acute myeloid leukemia and he had just six weeks to live. Now he’s been cancer-free for 50 years.

Filed Under: News Tagged With: 50 years, aml, cancer, cancer free, childhood cancer, diagnosis, drug, experimental, greg kindell, leukemia, live, newsok, OKC, Oklahoma Medical Research Foundation, OMRF, owasso, pryor, remission, survive, terminal, treatment, Tulsa, tulsa world

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

New colon cancer finding could lead to earlier diagnosis—and better outcomes

March 28, 2018

The most common method of screening for colon cancer is a colonoscopy. However, certain cancer-causing polyps can be easily missed during an examination.

Filed Under: News Tagged With: braf, cancer, CDC, changes, colon cancer, colorectal, Dave Jones, David, David Jones, death, detection, develop, diagnosis, discovery, fecal, Findings, genetic, Jones, killer, lab, leading, mutation, newsok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, outcomes, plos one, polyps, research, sample, science, scientist-news, test

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace